Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05458908 · ClinicalTrials.gov registry record · NA

ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS

A NA study of Stroke, sponsored by University Hospital, Basel, Switzerland.

Active
Registry status
NA
Development phase
252
Enrollment target
14
Study locations

NCT05458908 is a NA study of Stroke that is active but no longer recruiting, run by University Hospital, Basel, Switzerland. The registered enrollment target is 252 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 14 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05458908, a NA study of Stroke, is active but no longer recruiting, sponsored by University Hospital, Basel, Switzerland.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
252 participants
Enrollment target
14
Study locations

Study Summary

Stroke is one of the leading causes of mortality and disability worldwide. Optimization of intra-hospital pathways is as of today one of the most promising research topics in stroke treatment. A potential solution to shorten the time needed for current workflows, and therefore reperfusion, is to do both imaging and subsequent endovascular therapy (EVT) in the angiography suite using non-contrast syngo DynaCT Sine Spin (FDCT) for the exclusion of intracranial hemorrhage and flat detector CT angiography (FDCTA) or digital subtraction angiography for diagnosis of LVO. It is still a matter of debate if FDCT can reliably differentiate between ischemic and hemorrhagic stroke. This study aims to investigate if non-contrast syngo DynaCT Sine Spin imaging is non-inferior to non-contrast MDCT imaging regarding its sensitivity and specificity for the detection of intracranial hemorrhages.

Conditions Studied

Stroke

Interventions

  • DIAGNOSTIC_TEST Non-contrast cranial MDCT head scan
  • DIAGNOSTIC_TEST Non-contrast syngo DynaCT Sine Spin head scan and application software

Study Locations (14)

Other

  • HUS - Helsinki
  • CHRU de Tours - Tours
  • Hospital Vall d'Hebron - Barcelona
  • University Hospital Basel - Basel
  • Inselspital Bern - Bern
  • Kantonsspital Luzern - Lucerne

Illinois

  • AdvocateAurora Health - Chicago
  • Nortshore University Health System - Chicago

New York

  • New York University Langone Health - New York
  • Mount Sinai Health System - New York

Colorado

  • Swedish Medical Center - Denver

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Tennessee

  • Semmes Murphy Clinic - Memphis

Virginia

  • University of Virginia Health System - Charlottesville

Trial Details

FieldValue
Enrollment Target 252 participants
Start Date 2022-10-25
Est. Completion 2026-03-15
Phase NA

Sponsor

University Hospital, Basel, Switzerland

12 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05458908

The ClinicalTrials.gov registry entry for NCT05458908 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The listed sponsor is University Hospital, Basel, Switzerland, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Non-contrast cranial MDCT head scan is the first listed.

NCT05458908 reports 14 study locations spanning 7 distinct geographic areas - top geographies include Other, Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT05458908 about?

NCT05458908 is a clinical study titled "ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS". Stroke is one of the leading causes of mortality and disability worldwide. Optimization of intra-hospital pathways is as of today one of the most promising research topics in stroke treatment. A potential solution to shorten the time needed for current workflows, and therefore reperfusion, is to do ...

What is the current status of trial NCT05458908?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2022-10-25. Estimated completion is 2026-03-15.

What conditions does trial NCT05458908 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT05458908?

The interventions under investigation include: Non-contrast cranial MDCT head scan (DIAGNOSTIC_TEST), Non-contrast syngo DynaCT Sine Spin head scan and application software (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05458908?

This trial is sponsored by University Hospital, Basel, Switzerland, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05458908 being conducted?

This trial has 14 study locations across Colorado, Illinois, New York, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.